The recommended daily intake is 2.3 mg for men and 1.8 mg for women ( Manganese deficiency can present with skin and hair alterations (such as dermatitis, impaired growth of hair and nails, and color changes in hair and beard), nausea and vomiting, ataxia and loss of equilibrium, altered carbohydrate and lipid metabolism, skeletal changes with defects and poor bone formation, impaired reproductive function, and reduced concentrations of clotting proteins (354)
This effect may contribute to ensuring that a higher percentage of weight lost while using a GLP-1 medication comes from excess body fat rather than muscle mass
Endogenous ovarian hormones affect mitochondrial efficiency in cerebral endothelium via distinct regulation of PGC-1 isoforms
Patients interested in metabolic support during GLP-1 therapy benefit more from documented interventions: adequate protein intake (to preserve muscle during weight loss), regular resistance training, micronutrient screening (B12, iron, folate, electrolytes), and management of underlying thyroid or metabolic conditions